FOR RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION · 21+ ≥99% HPLC-VERIFIED · COA ON EVERY BATCH · UAE & GCC EXPRESS
Cart 0
CP10 CJC & IPA Blend
Certificate of analysisIssued per lot and matched to your shipment
Growth & Body research class

CJC & IPA Blend

4.0 1 verified review

CJC & IPA Blend is a 10mg synergistic formulation (5mg/5mg ratio) combining CJC-1295 No DAC and Ipamorelin to evaluate combined growth hormone release pathways.

PURITY
>= 99%
FORM
Lyophilized powder
BULK BUY OFFERS Larger configurations available on request · contact the desk.
AED 260
DOWNLOAD COA
Bacteriostatic Water
Add bacteriostatic water · 10 ml Required for reconstitution · not included with vials. Ships in the same cold-chain consignment.
AED 70
Ships in 1–2 business days 2–8°C cold chain Unbranded packaging
For research purposes only. Not for human consumption.

Research application

CJC & IPA Blend is a 10mg synergistic formulation combining equal parts CJC-1295 No DAC (5mg) and Ipamorelin (5mg) extensively evaluated in laboratory models investigating growth hormone axis mechanisms, alongside GHRH and GHSR receptor signaling. Supplied as a ≥99% pure lyophilized powder, this paired compound serves as a foundational tool for the precise evaluation of synergistic GH release pathways in vitro. This product is strictly for research purposes only and is not for human consumption.

For research purposes only. Not for human consumption.

RESEARCH AREAS
Growth hormone axis models
GHRH (Growth Hormone-Releasing Hormone) receptor signaling
GHSR (Growth Hormone Secretagogue Receptor) signaling

No lot report is published for this compound yet. Certificates are issued per lot and matched to the batch your order ships from, so the report is sent with the consignment.

BROWSE PUBLISHED LOT REPORTS
2–8°C

Before reconstitution

Store the lyophilized vial at 2–8°C, upright and protected from light. Keep it sealed until the moment of use.

BAC water

Reconstitution

Add bacteriostatic water slowly down the vial wall. Do not shake; swirl gently until the cake dissolves.

36 months

Shelf life

Lyophilized material carries a 36-month shelf life. The exact expiry for your batch is printed on its certificate of analysis.

HANDLING
Store at 2–8°C, upright
Keep sealed until use
Batch-matched COA included

Domestic freight

Dubai & SharjahAED 40
All other EmiratesAED 60
Orders above AED 1,000Complimentary

Transit

Internal processing takes 1–2 business days. Most domestic shipments arrive within 1–2 operational days, and orders finalised by 6:00 PM GST in central urban sectors frequently qualify for next-day temperature-controlled delivery. Remote western regions may need 2–3 days and dispatch in ambient packaging. Our logistics network operates exclusively within the UAE.

VERIFIED BUYERS ONLY

Researcher reviews

VERIFIED BUYERS

Customer Reviews

No reviews yet. Be the first to share your thoughts.

4.0
1 VERIFIED REVIEW
5 0%
4 100%
3 0%
2 0%
1 0%
100% of these reviews matched to an order record
10 AUG 2026

Blend ratio matched the certificate within tolerance.

VERIFIED PURCHASE
Research Fellow
SHARJAH

Frequently ordered together

ALL COMPOUNDS
IG1 IGF-1 LR3
GROWTH & BODY
IGF-1 LR3
1MG

IGF-1 LR3 is a high-impact anabolic signaling peptide evaluated for advanced research focused on aggressive growth phases, tissue development, and performance-driven body…

499 AED VIEW
CND10 >= 99% CJC-1295 No DAC
GROWTH & BODY
CJC-1295 No DAC
4.5 (2)
10 mg

CJC-1295 No DAC is a synthetic growth hormone-releasing hormone (GHRH) analogue evaluated for its role in pulsatile growth hormone release and broader…

600 AED VIEW
KP10 >= 99% KPV
RECOVERY & REPAIR
KPV
10 mg

KPV (Lysine-Proline-Valine) is a naturally occurring tripeptide derived from alpha-MSH evaluated for its role in inflammatory signaling, gut barrier integrity, and dermatological…

290 AED VIEW
P41 >= 99% PT-141
SKIN & BEAUTY
PT-141
5.0 (1)
10 mg

PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist evaluated for its role in MC4R pathway activation and complex neurobehavioral responses.

210 AED VIEW